Phase 3 Bladder Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged 21 years or older who are scheduled to have a radical cystectomy (surgery to remove the bladder) as a treatment for bladder cancer, performed by a participating surgeon at Memorial Sloan Kettering (MSK)
Who may not be able to join:
- For the part of the trial involving a medication called alvimopan: people who regularly take opioid pain medications on an ongoing basis are not eligible for that specific part of the trial
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Alvin Goh, MD, Memorial Sloan Kettering Cancer Center
Phone: 646-422-4667
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Length of hospital stay (Alvimopan); Symptomatic urinary tract infections (Stents)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.